PMG
GWPH

ProVise Management Group’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

ProVise Management Group’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-25
Closed -$3.49K – 345
2018
Q2 		$3.49K Buy
+25
New +$3.55K 0.26% 85

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

ProVise Management Group's GWPH Position: Q3 2018 in Review

ProVise Management Group sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2018, closing a stake of 25 shares — an estimated $3.49K sold.

ProVise Management Group first reported a position in GWPH in Q2 2018 and held it in 1 quarter. The position peaked at $3.49K in Q2 2018. 272 funds tracked by Wall St. Rank hold GWPH as of Q3 2018.

  • ProVise Management Group reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2018 after selling out during the quarter.
  • ProVise Management Group sold 25 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2018, an estimated $3.49K.
  • ProVise Management Group first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2018 and held it in 1 quarter.
  • ProVise Management Group's GW Pharmaceuticals Plc American Depositary Shares position peaked at $3.49K in Q2 2018.
  • 272 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2018.

Based on ProVise Management Group's 13F filing for Q3 2018, filed 5 Nov 2018.